Hope from Covid-19 treatment pills 10
20 months since Covid-19 started, the world has the first two special oral medications.
Pfizer later also announced the results of testing the antiviral drug paxlovid.
Beyond the numbers, the two antiretroviral drugs have fundamental differences.
Paxlovid also stops the virus from replicating, but by a different mechanism.
The above drugs also help treat diseases besides Covid-19.
How will paxlovid and molnupiravir be used?
The data Pfizer provided is only provisional and has not been reviewed by scientists.
The advantage of both drugs is oral use, different from existing methods, such as monoclonal antibodies that require injection or intravenous infusion.
This is simple but important, because treating acute infections like Covid-19 or influenza with antiviral drugs is inherently complex.
For example, people with Covid-19 should take molnupiravir as soon as possible after testing positive (ideally within 5 days of symptom onset).
Molnupiravir to treat Covid-19 from pharmaceutical company Merck, October 26.
Medicines need to be used for the right person.
It is possible that in the near future, if the two drugs are approved on a broader scale, national regulatory agencies will have complete instructions on how to prescribe molnupiravir and paxlovid (for example, over certain ages, or in
This is not the final step.
Covid-19 medicine in the future
Vaccines have been very successful in preventing severe disease and death after Covid-19, but specific drugs to treat the disease are still of great significance.
They are a group with underlying medical conditions and are taking certain medications that prevent the immune system from responding well enough to the vaccine after vaccination.
Experts hope there will be more special drugs to treat Covid-19.
Successes like molnupiravir and paxlovid are important, helping to open the door to new hope.
The problem with viral drugs is drug resistance, when the virus has evolved to adapt and is not affected by the drug.
